Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia

Haematologica. 2015 May;100(5):e196-9. doi: 10.3324/haematol.2014.115576. Epub 2014 Dec 31.
No abstract available

Keywords: CN-AML heterogeneity; NPM1 mutation; cytogenetically normal.

Publication types

  • Letter

MeSH terms

  • Biomarkers, Tumor / genetics
  • Humans
  • Karyotype*
  • Leukemia, Myeloid, Acute / genetics*
  • Leukemia, Myeloid, Acute / mortality*
  • Leukemia, Myeloid, Acute / therapy
  • Mutation*
  • Nuclear Proteins / genetics*
  • Nucleophosmin
  • Patient Outcome Assessment
  • Prognosis
  • Recurrence
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • NPM1 protein, human
  • Nuclear Proteins
  • Nucleophosmin